Regeneron Pharmaceuticals, Inc. Earnings Miss Estimates, But Sees Progress In Key Court Battle

Regeneron Pharmaceuticals Inc. early Thursday posted worse that expected fourth quarter earnings results, but the company won an appeal in a court case regarding one of its key drugs.